In the quest to outshine the broader market, stock pickers diligently seek out stocks with the potential for superior performance. Making the right choices can significantly elevate your wealth.
United Therapeutics Corp (NASDAQ: UTHR) closed the day trading at $276.47 down -1.74% from the previous closing price of $281.36. In other words, the price has decreased by -$1.74 from its previous closing price. On the day, 1.45 million shares were traded.
Ratios:
For a better understanding of UTHR, let’s look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 3.75 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 11.08. For the most recent quarter (mrq), Quick Ratio is recorded 5.23 and its Current Ratio is at 5.46. In the meantime, Its Debt-to-Equity ratio is 0.03 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Cantor Fitzgerald on June 02, 2025, initiated with a Overweight rating and assigned the stock a target price of $405.
BofA Securities Upgraded its Underperform to Neutral on April 21, 2025, while the target price for the stock was maintained at $314.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jun 09 ’25 when EDGEMOND JAMES sold 12,000 shares for $325.37 per share. The transaction valued at 3,904,496 led to the insider holds 8,118 shares of the business.
EDGEMOND JAMES sold 12,000 shares of UTHR for $3,909,893 on Jun 02 ’25. The CFO AND TREASURER now owns 8,118 shares after completing the transaction at $325.82 per share. On Jun 02 ’25, another insider, JAMES EDGEMOND, who serves as the Officer of the company, bought 111,500 shares for $318.85 each.
Valuation Measures:
As of this moment, United’s Price-to-Earnings (P/E) ratio for their current fiscal year is 11.03, and their Forward P/E ratio for the next fiscal year is 9.40. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 1.78. For the stock, the TTM Price-to-Sale (P/S) ratio is 4.17 while its Price-to-Book (P/B) ratio in mrq is 1.83.
Stock Price History:
Over the past 52 weeks, UTHR has reached a high of $417.82, while it has fallen to a 52-week low of $266.98. The 50-Day Moving Average of the stock is -8.36%, while the 200-Day Moving Average is calculated to be -19.04%.
Shares Statistics:
A total of 45.07M shares are outstanding, with a floating share count of 43.99M. Insiders hold about 2.49% of the company’s shares, while institutions hold 99.59% stake in the company.
